Cargando…

The efficacy of nebivolol on spontaneously hypertensive rats with overactive bladder – an experimental study

INTRODUCTION: Overactive bladder (OAB) is a disease that significantly decreases quality of life. Adverse effects of the drugs currently used in OAB treatment limit their use in patients with hypertension. Nebivolol (a β(1)-adrenergic receptor blocker) is approved for hypertension treatment, but als...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wróbel, Andrzej F., Stępniak, Anna, Bańczerowska-Górska, Małgorzata, Stangel-Wójcikiewicz, Klaudia, Czuczwar, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Experimental Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479596/ https://www.ncbi.nlm.nih.gov/pubmed/36160351 http://dx.doi.org/10.5114/aoms.2019.88279

Ejemplares similares

Blebbistatin, a Myosin II Inhibitor, Exerts Antidepressant-Like Activity and Suppresses Detrusor Overactivity in an Animal Model of Depression Coexisting with Overactive Bladder
por: Wróbel, Andrzej, et al.
Publicado: (2018)

The Assessment of the Efficacy of Imperatorin in Reducing Overactive Bladder Symptoms
por: Iwaniak, Paulina, et al.
Publicado: (2023)

New Kid on the Block: The Efficacy of Phytomedicine Extracts Urox(®) in Reducing Overactive Bladder Symptoms in Rats
por: Zapała, Łukasz, et al.
Publicado: (2022)

Blebbistatin reveals beneficial effects on the cystometric parameters in an animal model of detrusor overactivity
por: Wróbel, Andrzej, et al.
Publicado: (2019)

Overactive bladder syndrome pharmacotherapy: future treatment options
por: Wróbel, Andrzej
Publicado: (2015)

Human Papillomavirus Infection: Knowledge, Risk Perceptions and Behaviors among SMW and AFAB
por: Piróg, Magdalena, et al.
Publicado: (2022)

A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
por: John, Cockcroft
Publicado: (2007)

Heart rate variability in overactive bladder experimental model
por: Dobrek, Łukasz, et al.
Publicado: (2012)

Overactive bladder induces transient hypertension
por: Torimoto, Kazumasa, et al.
Publicado: (2018)

Arterial stiffness, hypertension, and rational use of nebivolol
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2009)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
por: Fortepiani, L.A., et al.
Publicado: (2002)

Efficacy of nebivolol‐valsartan single‐pill combination in obese and nonobese patients with hypertension
por: Mende, Christian W., et al.
Publicado: (2017)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
por: Rhee, Moo-Yong, et al.
Publicado: (2020)

Efficacy of tolterodine in children with overactive bladder
por: Koç, Başak, et al.
Publicado: (2020)

The Potential of Asiatic Acid in the Reversion of Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats
por: Wróbel, Andrzej, et al.
Publicado: (2021)

Comparison of Nebivolol and Bisoprolol for Cardiovascular Mortality in Hypertensive Patients
por: Kumar, Ratan, et al.
Publicado: (2019)

Data of Nebivolol on oxidative stress parameters in hypertensive patients
por: Barroso, Helena C., et al.
Publicado: (2022)

Efficacy and safety of nebivolol in hypertensive patients: a meta-analysis of randomized controlled trials
por: Liu, Jun-Ying, et al.
Publicado: (2020)

Overactive bladder
por: Wallace, Karen M., et al.
Publicado: (2015)

Efficacy and Safety of Propiverine in Children with Overactive Bladder
por: Kim, Woo Jung, et al.
Publicado: (2012)

3D Power Doppler vascular indices as a novel technique in assessing the outcome of minimally invasive techniques in uterine fibroids treatment
por: Stępniak, Anna, et al.
Publicado: (2017)

Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)

Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
por: Vaz-de-Melo, Renan Oliveira, et al.
Publicado: (2014)

Efficient myoblast expansion for regenerative medicine use
por: JAROCHA, DANUTA, et al.
Publicado: (2014)

Psychiatric History and Overactive Bladder Symptom Severity in Ambulatory Urogynecological Patients
por: Rogowski, Artur, et al.
Publicado: (2021)

An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
por: Frankel, Jeffrey, et al.
Publicado: (2022)

Postmenopausal overactive bladder
por: Tomaszewski, Jacek
Publicado: (2014)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Nebivolol And Quinapril Reduce P-Wave Duration And Dispersion In Hypertensive Patients
por: Korkmaz, Hasan, et al.
Publicado: (2009)

Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension
por: Yazici, Huseyin Ugur, et al.
Publicado: (2013)

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data
por: Giles, Thomas D., et al.
Publicado: (2017)

Comparison of Effect of Nebivolol and Bisoprolol on Sexual Function of Hypertensive Female Patients
por: Kumar, Nomesh, et al.
Publicado: (2021)

The Cannabinoid Ligand Arachidonyl-2′-Chloroethylamide (ACEA) Ameliorates Depressive and Overactive Bladder Symptoms in a Corticosterone-Induced Female Wistar Rat Model
por: Zapała, Łukasz, et al.
Publicado: (2023)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
por: Rousselin, Yoann, et al.
Publicado: (2012)

Posterior tibial nerve stimulation for overactive bladder—techniques and efficacy
por: Bhide, Alka A., et al.
Publicado: (2019)

Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
por: Patel, Rachna S., et al.
Publicado: (2014)

Efficacy and safety of nebivolol in Korean patients with hypertension by age and sex: a subanalysis from the BENEFIT-KOREA study
por: Cho, Kyoung Im, et al.
Publicado: (2021)

Pharmacologic management of overactive bladder
por: Lam, Sum, et al.
Publicado: (2007)

Medical management of overactive bladder
por: Ubee, Sarvpreet S., et al.
Publicado: (2010)

Overactive bladder in the vulnerable elderly
por: Wolff, Gillian F, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n3g2qha9le2a6pc1hmgehdi0h7